11-10-2022

Modavar Pharmaceuticals Launches Paroxetine ER Tablets

Washington, D.C., December 10, 2022 – Modavar Pharmaceuticals announced today that it has launched Paroxetine ER Tablets.  The launch of the three strengths of Paroxetine (12.5mg, 25mg and 37.5mg in bottles of 30’s) adds to the growing line of products in the Modavar portfolio.  Paxil® CR belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs).  Serotonin is a

09-27-2022

Modavar Pharmaceuticals Launches Raloxifene Tablets

Washington, D.C., September 27, 2022 - Modavar Phramaceuticals announced today that it has launched Raloxifene Tablets.  The launch of the three SKU's of Raloxifene 60mg (30's, 100's and 1,000's) adds to the growing line of products in the Modavar portfolio.  The product is available immediately and is AB-rated to Eli Lilly's Evista®.  Total market sales for this product are a

05-12-2022

Modavar Pharmaceuticals Launches Rivastigmine Capsules

Washington, D.C., May 12, 2022 – Modavar Pharmaceuticals announced today that it has launched Rivastigmine Capsules.  The launch of the four strengths of Rivastigmine (1.5mg, 3mg, 4.5mg and 6mg) adds to the growing line of products in the Modavar portfolio.  The product is available immediately and is AB-rated to Novartis’ Exelon®.  Total market sales for this product are approximately

05-12-2022

Modavar Pharmaceuticals Launches Celecoxib Capsules

Washington, D.C., May 12, 2022 – Modavar Pharmaceuticals announced today that it has launched Celecoxib Capsules.  The launch of the four strengths of Celecoxib (50mg, 100mg, 200mg and 400mg) adds to the growing line of products in the Modavar portfolio.  The product is available immediately and is AB-rated to Pfizer’s Celebrex®.  Total market sales for this product are app

03-16-2022

Modavar Pharmaceuticals Launches Nebivolol Tablets

Washington, D.C., March 16, 2022 – Modavar Pharmaceuticals announced today that it has launched Nebivolol Tablets.  The launch of the four strengths of Nebivolol (2.5mg, 5mg, 10mg and 20mg) is the second of many launches the company anticipates in the next 6 months under the Modavar label.  The product is available immediately and is AB-rated to Allergan’s Bystolic®.  Tota